1173 participants
A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2026-05-26
- Completion:
- 2029-06-01
Conditions
- Non-small Cell Lung Cancer(NSCLC)
- EGFR Mutant
Interventions
- DRUG
No Results Yet